GFP: I'd like for the stock to stay in it's trading range until spring. I'd like to eventually get to 10,000 shares and I hope I can obtain them for less than $40K. The company also has a drug candidate against gram positive bacteria. With resistance developing with all other current antibiotics another AB targeting bacteria in a different way will always be interesting to big Pharma.